Fundraising FoxCantargia
1 known investors
Find your way into Cantargia
Sign up to see every warm intro you have to Cantargia
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Cantargia team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Cantargia is a company listed on Nasdaq Stockholm (Small Cap). The page presents shareholder and stock information, including its largest owners.
Founders & leadership
HH
Hilde H. SteinegerHilde H. Steineger holds a PhD in medical biochemistry from the University of Oslo and an M.Sc. in molecular biology/biotechnology. She has held CEO positions at Cantargia (an oncology company) and Staten Biotechnology, co-founded and served as COO of NorthSea Therapeutics, and spent six years as Vice President of Business Development at Pronova BioPharma; she has also held leadership roles at BASF in innovation management and worked as a financial analyst and venture capitalist focused on life sciences.
Investors · 1
Sunstone Capitallisted by Sunstone CapitalFrederiksberg
How we know: Sunstone Capital's portfolio page · the VCSheet dataset · Not right? Tell us
Frequently asked questions
- What does Cantargia do?
- Cantargia is a company listed on Nasdaq Stockholm (Small Cap). The page presents shareholder and stock information, including its largest owners.
- Who are Cantargia's investors?
- Cantargia's investors include Sunstone Capital.